Tag: Reduced administration of DAPT as an option post-stents

Reduced administration of DAPT as an option post-stents

October 22, 2018

Orbus Neich released the results from their Reduce trial, providing fresh insight into the optimal treatment of patients with acute coronary syndrome (ACS) using the Combo dual therapy stent. Combo is a dual therapy stent designed to repair vessel injury and regenerate endothelium through a combination of endothelial progenitor cell (EPC) capture technology and a […]

Continue Reading